Pibrentasvir – 25 mg

Brand:
Cayman
CAS:
1353900-92-1
Storage:
-20
UN-No:
Non-Hazardous - /

Pibrentasvir is an inhibitor of hepatitis C virus (HCV) non-structural protein 5A (NS5A).{51095} It inhibits HCV replication in stable replicon cell lines containing NS5A from genotypes 1-6 (EC50s = 1.4-4.3 pM). Pibrentasvir acts synergistically with the HCV NS3/4A protease inhibitor glecaprevir to inhibit HCV genotype 1b-Con1 replication in replicon cells.{51096} Formulations containing pibrentasvir have been used in combination with glecaprevir in the treatment of HCV infection.  

 

Available on backorder

SKU: 27546 - 25 mg Category:

Description

An HCV NS5A inhibitor; inhibits HCV replication in stable replicon cell lines containing NS5A from genotypes 1-6 (EC50s = 1.4-4.3 pM); acts synergistically with glecaprevir to inhibit HCV genotype 1b-Con1 replication in replicon cells


Formal name: N,N’-[[(2R,5R)-1-[3,5-difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis[(6-fluoro-1H-benzimidazole-5,2-diyl)-(2S)-2,1-pyrrolidinediyl[(1S)-1-[(1R)-1-methoxyethyl]-2-oxo-2,1-ethanediyl]]]bis-carbamic acid, dimethyl ester

Synonyms: 

Molecular weight: 1,113.20

CAS: 1353900-92-1

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Hepatitis